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Summary A 42-year-old male suffered from ST elevation myocardial infarction and underwent
successful percutaneous coronary intervention (PCI) of the left anterior descending coronary
artery (LAD) with drug-eluting stent using intravenous glycoprotein IIB/IIIa inhibitor (Clotinab®,
Isu Abxis). Five hours after PCI, the patient developed cold sweating and went into a stupor.
Urgent 2D-echocardiography showed a large amount of pericardial effusion and akinesia in
the LAD territory. A repeat emergent angiography (CAG) was done to ascertain whether acute
stent thrombosis or coronary perforation had occurred after PCI. The CAG showed, however,
no leakage of dye or thrombus in any coronary arteries with a patent stent in the middle
LAD. Approximately 200 cm3 of bloody pericardial effusion was drained, and his blood pressure
returned to normal immediately after pericardiocentesis. Seven days later, he again developed
sudden hypotension, bradycardia, and loss of consciousness. The ECG showed ST elevation in
V1—V6 and 2D-echocardiography showed scanty pericardial effusion. Emergent CAG showed
total occlusion of the LAD due to subacute stent thrombosis. He was successfully treated with
balloon angioplasty and was discharged with dual anti-platelet therapy. A follow-up CAG after
9 months showed good ﬂow without residual stenosis across the stented segment.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
∗ Corresponding author. Tel.: +82 62 220 6243; fax: +82 62 228 7174.
E-mail addresses:myungho@chollian.net, myungho@chol.com (M.H. Jeong).
1878-5409/$ — see front matter © 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.jccase.2009.08.004
eI
B
t
w
p
b
c
o
a
a
C
A
w
f
m
i
r
n
s
S
r
T
k
a
t
u
s
t
o
a
A
s
(
l
l
(
p
o
M
a
F
l
s
ﬂ
v
p
d
p
S
U
d
t
a
f
n
p
w
o
p
c
1
H
d
e
s
d
c
2
E
t
a
f
b
a
l
w
c
c
g
s76
ntroduction
leeding and thrombosis are always a dilemma during the
reatment of acute coronary syndrome. Especially, in patient
ith drug-eluting stent implantation, appropriate anti-
latelet therapy is important to prevent stent thrombosis,
ut there is a potential risk for serious hemorrhagic compli-
ations. We experienced a case of sequential development
f pericardial tamponade and subacute stent thrombosis
fter primary percutaneous coronary intervention (PCI) for
cute ST-segment elevation myocardial infarction.
ase report
42-year-old man presented to the Emergency Department
ith continuous chest pain of 4 h duration. He had no risk
actors for coronary artery disease, and he was not on any
edication at the time of admission. Upon physical exam-
nation his blood pressure was 150/90mmHg and his heart
ate was 104 beats per minute, with regular heartbeat and
ormal S1 and S2 sounds. On auscultation, his breathing
ound was clear. The initial electrocardiogram (ECG) showed
T-segment elevation (STE) in lead V1 through V6 with recip-
ocal ST-segment depression in leads II, III, and aVF (Fig. 1).
he levels of cardiac enzymes were elevated: creatine
inase (CK) 688 U/L (35—172), CK-MB 20.6U/L (2.3—9.5),
nd troponin-I 6.18 ng/mL (0—0.05). Conventional unfrac-
ionated heparin was administered at an initial dose of 5000
nits, followed by continuous infusion of 1000 units per hour,
ubsequently targeting an activated partial thromboplastin
ime of 1.5—2.0 times baseline. Additionally, loading doses
f aspirin (300mg) and clopidogrel (300mg) were given and
bciximab, a glycoprotein IIb/IIIa inhibitor (Clotinab®, Isu
bxis) was infused (0.25mg/kg bolus and 10g/min infu-
ion for 12 h). One hour later, emergent coronary angiogram
CAG) revealed thrombotic total occlusion of the middle
eft anterior descending coronary artery (LAD) with no col-
aterals from the left circumﬂex or right coronary artery
Fig. 2A). After wiring into the LAD, balloon angioplasty was
erformed with a 3.0mm balloon, followed by deployment
f a 3.5mm× 24mm zotarolimus-eluting stent (Endeavor®,
edtronic) at 14 atm. But there remained residual thrombi
nd additional balloon dilation was performed. The ﬁnal CAG
igure 1 Electrocardiogram showed ST-segment elevation in the p
eads II, III, and aVF.
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howed thrombolysis in myocardial infarction III antegrade
ow but residual stenosis distal to the stent (Fig. 2B). The
ital signs were stable during and following the PCI and the
atient did not complain of any symptoms such as chest
iscomfort or dyspnea. Five hours after PCI, however, the
atient developed cold sweating and went into a stupor.
ubsequently, his blood pressure decreased to 70/40mmHg.
rgent 2D-echocardiography showed a large amount of echo
ense pericardial effusion and akinesia in the LAD terri-
ory (Fig. 3). A repeat emergent angiography was done to
scertain whether acute stent thrombosis or coronary per-
oration had occurred after PCI. The CAG showed, however,
o leakage of dye or thrombus in any coronary arteries with a
atent stent in the middle LAD. Emergent pericardiocentesis
as performed via apical approach. Approximately 200 cm3
f bloody pericardial effusion was drained, and his blood
ressure returned to normal immediately after pericardio-
entesis. Peak levels of elevated cardiac enzymes: CK-MB
98.3 IU/L (2.3—9.5) and troponin-I 104.1 ng/mL (0—0.05).
eparin was not administered after pericardiocentesis, but
ual anti-platelet therapy was maintained. A follow-up 2D-
chocardiography 3 days after pericardiocentesis showed
canty pericardial effusion. Seven days later, he again
eveloped sudden hypotension, bradycardia, and loss of
onsciousness. The ECG showed ST elevation in V1—V6 and
D-echocardiography showed scanty pericardial effusion.
mergent CAG was done, which showed total occlusion of
he LAD due to subacute stent thrombosis (Fig. 4A). Balloon
ngioplasty using 2.0mm and 3.5 balloons was performed,
ollowed by thrombus aspiration. A huge amount of throm-
us was aspirated from that lesion. Then, additional balloon
ngioplasty was done several times using a 3.5mm bal-
oon in the LAD. The ﬁnal CAG showed good distal ﬂow
ithout residual thrombus burden (Fig. 4B). He was dis-
harged with dual anti-platelet therapy (aspirin 300mg and
lopidogrel 75mg). A follow-up CAG after 9 months showed
ood ﬂow without residual stenosis across the stented
egment.recordial leads V1—V6 and reciprocal ST-segment depression in
iscussion
here are several reasons that could possibly explain the
evelopment of pericardial tamponade and myocardial
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Figure 2 Coronary angiogram revealed thrombotic total
occlusion of the mid-left anterior descending artery (A,
white arrow). Balloon angioplasty was performed with a
3.0mm balloon, followed by deployment of a 3.5mm× 24mm
zotarolimus-eluting stent at 14 atm. The ﬁnal coronary
Figure 3 2D-echocardiogram showing a large amount of
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rangiogram showed thrombolysis in myocardial infarction III
antegrade ﬂow but residual stenosis distal to the stent (B).
infarction in our patient after PCI: coronary artery per-
foration, hemorrhagic pericarditis, and cardiac free wall
rupture.
Our patient had no angiographic appearance of per-
foration that is no extraluminal crater, extravasation, or
contrast streaming into the pericardium or anatomic cav-
ity chamber [1]. It has been described that tamponade due
to perforation may occur up to 24 h after the angioplasty
procedure, but the absence of any obvious sign of coronary
perforation in our case makes this diagnosis very unlikely.
Hemorrhagic pericarditis was also considered as the cause
of cardiac tamponade in our patient. It developed because of
t
o
h
m
oericardial effusion (PE) with akinesia in the left anterior
escending artery territory.
everal causes such as complication of anti-thrombotic ther-
py (thrombolytic therapy, glycoprotein IIb/IIIa inhibitor) or
emorrhagic infarction followed by late reperfusion therapy.
bciximab is currently used for prevention of ischemic com-
lications in patients undergoing PCI and in patients with
nstable angina when PCI is planned within 24 h. Despite
he proven effect of glycoprotein IIb/IIIa inhibitors, their use
s associated with bleeding complications such as pseudoa-
eurysm (0.5—0.9%), arteriovenous ﬁstula (0.2—2.1%), and
etroperitoneal hematoma (0.15—0.44%) [2]. Also, hemor-
hagic pericarditis leading to cardiac tamponade is rare, but
here were several reports after PCI associated with the use
f abciximab [3]. Hemorrhagic infarction and subsequent
emorrhagic pericarditis due to late reperfusion therapy
ay be considered, but symptom onset to balloon time was
nly 4 h, making this diagnosis unlikely in our patient.
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Figure 4 Coronary angiogram showed thrombotic total occlu-
sion of the left anterior descending artery due to subacute stent
thrombosis (A, white arrow). Final coronary angiogram after
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[alloon angioplasty with adjunct thrombus aspiration showed
ood distal ﬂow without residual thrombus burden (B).
Cardiac free wall rupture following acute myocardial
nfarction may lead to hemopericardium and cardiac tam-
onade. There are two distinct types, based on the clinical
ourse: acute (blow out type) and subacute (oozing type)
ree wall rupture [4]. When the acute cardiac rupture
ccurs, it usually results in an abrupt hemodynamic collapse
ith cardiac tamponade and electromechanical dissocia-
ion. On the other hand, the rupture can be sealed by the
picardium or by a hematoma on the epicardial surface of
he heart. This situation — subacute or ‘‘oozing type’’ rup-
ure, may evolve over hours or even days, and presents
ainly with pericardial effusion-related signs and symptoms
5]. In our patient, clinical signs of cardiac tamponade,
ericardial effusion greater than 5mm thickness, echogenic
[S.S. Kim et al.
ericardial effusion, and bloody pericardial effusion by
ericardiocentesis may suggest subacute type cardiac rup-
ure [6]. Emergency cardiac surgery may be usually the
vailable therapeutic option in the cardiac rupture. How-
ver, because initial aspiration of pericardial ﬂuid leads
o rapid improvement of the clinical condition and scanty
ericardial effusion by follow-up 2D-echocardiography, we
onsider a conservative approach (prolonged bed rest, beta
locker).
Stent thrombosis is an uncommon but serious complica-
ion of coronary artery stents that often presents as death
r myocardial infarction. Several factors were identiﬁed to
e associated with stent thrombosis, including older age,
lack race, diabetes mellitus, bifurcation lesion, in-stent
estenosis lesion, procedure-related factors such as stent
alapposition, greater stent length, postprocedure acute
enal failure, and non-compliance to anti-platelet therapy
7]. It was thought that following subacute stent thrombo-
is might be due to inappropriate anti-thrombotic therapy
ecause of bleeding complication in our patient. We treated
his patient with dual anti-platelet therapy (aspirin 100mg
aily, clopidogrel 75mg daily), but heparinization was not
sed due to pericardial tamponade. Subacute stent throm-
osis may be caused by high thrombotic burden and early
topping of heparinization.
Bleeding complications and thrombosis are always a
ilemma during the treatment of acute coronary syndrome.
specially, in patient with drug-eluting stent implantation,
ppropriate anti-thrombotic therapy is important to prevent
tent thrombosis but there is a potential risk for seri-
us hemorrhagic complications. This case suggests that we
hould consider early cardiac tamponade and stent thrombo-
is when the patient with ST-segment elevation myocardial
nfarction develops hypotension and loss of consciousness
fter apparently successful PCI. Careful monitoring of post-
nfarction complications should be performed in acute
oronary syndrome after PCI.
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